Trial Condition(s):

Heart Failure

A study to observe treatment patterns in patients in Colombia who have heart failure (HEATCO)

Bayer Identifier:

21798

ClinicalTrials.gov Identifier:

NCT05036967

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Researchers want to learn more about the treatments doctors choose to treat heart failure.

Heart failure means the heart isn’t pumping as well as it should be. Heart failure can lead to other serious medical conditions, and it can lead to hospitalization or death.

There are different types of treatments available for people who have heart failure, and these work in different ways. In this study, the researchers will collect information about Colombian patients who have heart failure.

The main purpose of this study is to identify patterns in the treatments that doctors first prescribe to heart failure patients in Columbia. To do this, the researchers will review information from the patients’ medical records and from a drug-dispensing database.

The study will include adult patients who have been diagnosed with heart failure in Columbia from June 1st, 2019 to May 31st, 2020.

There will be no required visits, treatments, or procedures in this study. The researchers will collect information about the treatments the patients have been prescribed by their own doctors.

Inclusion Criteria
- Adult patients (older than 18 years) with a diagnosis of HF according to ICD-10 with a dispensing of some medicine and it is registered in the database of Audifarma S.A. during the observation period will be included
Exclusion Criteria
- Patients with Acute HF without prior diagnosis of HF

Trial Summary

Enrollment Goal
1000
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Unspecified
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many Locations

Many Locations, Colombia

Status
Recruiting
 

Trial Design